Search - tctmd.com

Displaying 421 - 440 of 1375

Sort: Relevancy | Date

Debate: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients - Pro: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients

Presentation TCT 2019

Pro: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients

Presenter: C. Michael Gibson

September 27, 2019

Presentation TCT 2019

Excel: Extended Follow-Up and Most Important Substudies

Presenter: Ori Ben-Yehuda

September 27, 2019

Presentation TCT 2019

A Look Ahead for IVL

Presenter: Dean Kereiakes

September 27, 2019

Presentation TCT 2019

Update on Coronary IVL: Real-World Experiences

Presenter: Jonathan Hill

September 27, 2019

Presentation TCT 2019

No Access, No Problem

Presenter: Rajiv Tayal

September 27, 2019

Presentation TCT 2019

Potential of NaF PET Imaging for Vulnerable Plaque and Patient Identification

Presenter: Bon-Kwon Koo

September 27, 2019

Presentation TCT 2019

Going Out on a Limb: A Call to Action for Critical Limb Ischemia in the Underserved

Presenter: Lee Kirksey

September 27, 2019

Presentation TCT 2019

Answers and Questions After AUGUSTUS

Presenter: C. Michael Gibson

September 27, 2019

Presentation TCT 2019

Integration of Non-Invasive and Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Presenter: Ryan Madder

September 27, 2019

Presentation TCT 2019

Look Mom, No Recoil!

Presenter: Peter Soukas

September 27, 2019

Presentation TCT 2019

Non-Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Presenter: James Min

September 27, 2019

Presentation TCT 2019

PCI in the Alaskan Native/American Indian Population: Unique Challenges and Potential Solutions

Presenter: George Chrysant

September 27, 2019

Presentation TCT 2019

Overview of Expanding Applications

Presenter: Dean Kereiakes

September 27, 2019

Presentation TCT 2019

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

Presenter: Farouc Jaffer

September 27, 2019

Presentation TCT 2019

Minority Women Undergoing PCI: Optimizing Outcomes in the New High-Risk PCI Cohort

Presenter: Kelly Epps

September 27, 2019

Presentation TCT 2019

Introduction and Overview of IVL

Presenter: Jonathan Hill

September 27, 2019

Presentation TCT 2019

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Presenter: Peter Stone

September 27, 2019

Presentation TCT 2019

Drug-Coated Balloons in the Periphery: Red Alert or Red Herring?

Presenter: Eric Secemsky

September 27, 2019

Presentation TCT 2019

Treatment of Vulnerable Patients and Plaques: PREVENT Rationale and Update

Presenter: Seung-Jung Park

September 27, 2019

Presentation TCT 2019

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Presenter: David Erlinge

September 27, 2019

Advertisement

Pro: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients

Excel: Extended Follow-Up and Most Important Substudies

A Look Ahead for IVL

Update on Coronary IVL: Real-World Experiences

No Access, No Problem

Potential of NaF PET Imaging for Vulnerable Plaque and Patient Identification

Going Out on a Limb: A Call to Action for Critical Limb Ischemia in the Underserved

Answers and Questions After AUGUSTUS

Integration of Non-Invasive and Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Look Mom, No Recoil!

Non-Invasive Imaging for the Detection of Vulnerable Plaques and Patients

PCI in the Alaskan Native/American Indian Population: Unique Challenges and Potential Solutions

Overview of Expanding Applications

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

Minority Women Undergoing PCI: Optimizing Outcomes in the New High-Risk PCI Cohort

Introduction and Overview of IVL

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Drug-Coated Balloons in the Periphery: Red Alert or Red Herring?

Treatment of Vulnerable Patients and Plaques: PREVENT Rationale and Update

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content